The vascular disrupting agents market is projected to be worth USD 2 billion by 2030
Vascular disrupting agents (VDAs) are the novel oncology drugs being developed to more specifically combat complex, life threatening cancer indications   London   Roots Analysis has announced the addition of “Vascular Disrupting Agents Market, 2021-2030” report to its list of offerings.   Despite multiple cancer treatment options, there is an evident unmet need for...
0 Comments 0 Shares